Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole for cognitive recovery after severe traumatic brain injury
IRCT20241230064217N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of riluzole in traumatic brain injury (TBI) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Improving the cognitive status of patients. Started Mar 2025; status: completed.
02
Drugs
riluzole
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20241230064217N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241230064217N1.